Concord Drugs Ltd.
BSE: 538965 | Sector: Health care |
NSE: N.A. | ISIN Code: INE858L01010 |
BSE 00:00 | 07 Jul | 27.70 |
-0.75 (-2.64%) |
OPEN
28.35 |
HIGH
28.35 |
LOW
26.10 |
NSE 05:30 | 01 Jan | Concord Drugs Ltd |
OPEN | 28.35 |
PREVIOUS CLOSE | 28.45 |
VOLUME | 3887 |
52-Week high | 37.40 |
52-Week low | 19.50 |
P/E | 15.22 |
Mkt Cap.(Rs cr) | 24 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Concord Drugs Ltd.
CONCORD DRUGS LIMITED is a public limited company established in 1995 is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals Dry powder ) Tissue Bio-Adhesive tablets capsules and ophthalmic preparations and Ready-to-fill Pellets.State of the art technology having dedicated manufacturing facilitie...> More
Concord Drugs Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
24 | |
EPS - TTM | (![]() |
[*S] | 1.82 |
P/E Ratio | (X) | [*S] | 15.22 |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | - | |
Latest Dividend Date | - | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 32.44 |
P/B Ratio | (![]() |
[*S] | 0.85 |
Announcement
-
Related Party Disclosure Under Regulation 23(9) Of SEBI(LODR) Regulation 2015
-
Announcement under Regulation 30 (LODR)-Resignation of Director
-
Audited Financial Results For Quarter And Financial Year Ended 31St March 2022.
-
Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31.03.2022
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Concord Drugs Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 15.46 | 8.35 | 85.15 |
Other Income | 0.02 | 0.26 | -92.31 |
Total Income | 15.49 | 8.61 | 79.91 |
Total Expenses | 14.81 | 7.62 | 94.36 |
Operating Profit | 0.68 | 0.99 | -31.31 |
Net Profit | 0.03 | 0.34 | -91.18 |
Equity Capital | 8.74 | 8.74 | - |
Concord Drugs Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Vista Pharma. | 7.00 | 0.14 | 25.76 |
Roopa Industries | 31.85 | 1.27 | 25.07 |
Guj. Terce Labs. | 33.00 | 0.92 | 24.49 |
Concord Drugs | 27.70 | -2.64 | 24.21 |
Transchem | 19.30 | 0.52 | 23.62 |
Earum Pharmaceu. | 3.79 | 4.99 | 23.38 |
Shukra Pharma. | 143.60 | 4.97 | 22.55 |
Concord Drugs Ltd - SHAREHOLDING PATTERN
|
|
Concord Drugs Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -1.95% | NA | 2.19% | 2.23% |
1 Month | 5.32% | NA | -1.69% | -1.73% |
3 Month | -7.36% | NA | -8.23% | -8.54% |
6 Month | -20.17% | NA | -9.32% | -9.43% |
1 Year | -15.16% | NA | 2.12% | 1.59% |
3 Year | 25.91% | NA | 37.11% | 36.59% |
Concord Drugs Ltd - STOCK STRENGTH
Today's Low/High | 26.10 | 28.35 | |
Week Low/High | 23.70 | 31.00 | |
Month Low/High | 19.50 | 31.00 | |
YEAR Low/High | 19.50 | 37.00 | |
All TIME Low/High | 11.68 | 91.00 |
Quick Links for Concord Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices